Several studies have demonstrated that increased VEGF, HIF-lα, and PTEN expression in ovarian cancer cells can be used as predictors of metastasis and prognosis (39), and that increased plasma VEGF levels in ovarian cancer patients correlate to advanced tumor stage and a poor outcome (40). Here, PTEN is linked to neoplasm.